基本医疗保障制度下完善我国罕见病高价值治疗药物医保准入的思路探讨
朱琳, 胡嘉浩, 刘宇晗, 李芬, 金春林
基本医疗保障制度下完善我国罕见病高价值治疗药物医保准入的思路探讨
Discussion on improving the medical insurance access of high-value orphan drugs in China under the basic medical insurance system
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |